Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism

Neurosci Lett. 1999 May 7;266(2):149-51. doi: 10.1016/s0304-3940(99)00278-5.

Abstract

Brain tissue of 50 patients with morphological confirmed Parkinson's disease (PD), blood samples from 149 patients with clinical parkinsonism and from 96 healthy control subjects were collected. Apolipoprotein-E (apo E) and cytochrome P450 2D6 (CYP2D6) genotyping were performed by PCR followed by restriction fragment analysis. A significantly higher allele frequency of CYP2D6*4 was found in patients with PD (35%) but not with parkinsonism (14.1%) compared to control subjects (19.8%). The combined alleles frequency of CYP2D6*3 + apoE4 was significantly higher not only in the PD group (33.3%) but also in patients with parkinsonism (22.3%) compared to control subjects (1.6%). These results suggest that there is a substantial overlap not only in the clinical manifestation but also in the genetic risk factors between Parkinson's and Alzheimer's diseases.

MeSH terms

  • Apolipoproteins E / genetics*
  • Case-Control Studies
  • Cytochrome P-450 CYP2D6 / genetics*
  • Cytochrome P-450 Enzyme System / genetics*
  • Disease Progression
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Humans
  • Parkinson Disease / genetics*
  • Parkinson Disease / pathology
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*

Substances

  • Apolipoproteins E
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP2D6